Rapid AST and sepsis management in real-world hospital settings
Tuesday , December 16, at 15:00 GMT | 16:00 CET | 10:00 EST | 7:00 PST
Rapid antimicrobial susceptibility testing (AST) holds transformative potential for improving sepsis outcomes, yet its clinical adoption remains limited. This webinar brings together leading experts to explore how to bridge the gap between technological innovation and real-world adoption of rapid AST, a crucial step in improving sepsis management and patient outcomes.
Join Prof. Giuliana Lo Cascio and Prof. Holger Rohde as they discuss what it takes to move rapid AST from proof of concept to routine hospital practice, addressing the operational, technical, and collaborative challenges that still limit its widespread adoption.
Dr. Giuliana Lo Cascio, expert in clinical microbiology and hospital diagnostics, will share hands-on insights on integrating rapid AST into everyday laboratory workflows and clinical decision-making. Dr. Holger Rohde, expert in clinical microbiology, a leading researcher in diagnostic and molecular microbiology, will add an innovation-driven perspective on validation, standardization, and the clinical impact of emerging AST technologies.
Key learning objectives:
- Understand the main operational and technical barriers that limit the adoption of rapid AST in clinical laboratories.
- Learn how technology design can simplify workflows, improve throughput, and increase confidence in rapid results.
- Gain insight into how collaboration between clinicians, microbiologists, and hospital management can support successful implementation.
- Hear perspectives on the practical, organizational, and economic factors influencing the transition from innovation to routine hospital practice
- Learn how hospitals and labs can optimize adoption now
Who should attend?
- Clinical microbiologists and laboratory managers
- Clinicians and antimicrobial stewardship teams
- Hospital administrators and healthcare leaders
- Researchers and diagnostic technology developers
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Giuliana Lo Cascio is a clinical microbiologist and medical doctor based in Italy, currently serving as Director of the Unit of Microbiology and Virology at Ospedale “Guglielmo da Saliceto” in Piacenza. With extensive experience in clinical diagnostics and hospital microbiology, she specializes in antimicrobial susceptibility testing, infectious disease surveillance, and laboratory workflow optimization. Dr. Lo Cascio is deeply engaged in translating diagnostic innovation into practical, real-world hospital settings, with a focus on improving patient outcomes in sepsis care through rapid, reliable diagnostic solutions.
Dr. Holger Rohde is the deputy head of the Institute for Medical Microbiology, Virology and Hygiene at the Universitätsklinikum Hamburg-Eppendorf (UKE), Germany, and Professor of Molecular Microbiology. Dr. Rohde is a senior physician and medical specialist in microbiology, virology, and infectious disease epidemiology. His research focuses on the role of biofilm formation in implant associated staphylococcal infections. He is an advocate of rapid diagnostics and has ample experience validating innovative technologies. Dr. Rohde is also the Director of the ESCMID AMR Action Subcommittee.
Moderator
